AONN+ Midyear 2022
FRI07 - ERLEADA: For the Treatment of Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC) and Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC)| Presentation by Janssen
May 13, 2022 12:00pm ‐ May 13, 2022 1:15pm
, DNP, APRN, BC, AOCN, Kapin Communication, LLC
You must be logged in and own this session in order to post comments.
© 2022 Digitell, Inc. All Rights Reserved